316 related articles for article (PubMed ID: 18226173)
1. Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis.
Bopp C; Bierhaus A; Hofer S; Bouchon A; Nawroth PP; Martin E; Weigand MA
Crit Care; 2008; 12(1):201. PubMed ID: 18226173
[TBL] [Abstract][Full Text] [Related]
2. Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways.
Li K; Yang J; Han X
Int Immunopharmacol; 2016 May; 34():114-128. PubMed ID: 26945830
[TBL] [Abstract][Full Text] [Related]
3. Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?
Christaki E; Lazaridis N; Opal SM
Curr Opin Infect Dis; 2012 Jun; 25(3):304-11. PubMed ID: 22327468
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.
Zhang H; Mao YF; Zhao Y; Xu DF; Wang Y; Xu CF; Dong WW; Zhu XY; Ding N; Jiang L; Liu YJ
Oxid Med Cell Longev; 2021; 2021():8889313. PubMed ID: 33628393
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.
Lutterloh EC; Opal SM; Pittman DD; Keith JC; Tan XY; Clancy BM; Palmer H; Milarski K; Sun Y; Palardy JE; Parejo NA; Kessimian N
Crit Care; 2007; 11(6):R122. PubMed ID: 18042296
[TBL] [Abstract][Full Text] [Related]
6. Understanding RAGE, the receptor for advanced glycation end products.
Bierhaus A; Humpert PM; Morcos M; Wendt T; Chavakis T; Arnold B; Stern DM; Nawroth PP
J Mol Med (Berl); 2005 Nov; 83(11):876-86. PubMed ID: 16133426
[TBL] [Abstract][Full Text] [Related]
7. Targeting RAGE in sepsis.
van Zoelen MA; van der Poll T
Crit Care; 2008; 12(1):103. PubMed ID: 18254937
[TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.
Stern D; Yan SD; Yan SF; Schmidt AM
Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.
Liliensiek B; Weigand MA; Bierhaus A; Nicklas W; Kasper M; Hofer S; Plachky J; Gröne HJ; Kurschus FC; Schmidt AM; Yan SD; Martin E; Schleicher E; Stern DM; Hämmerling G Gü; Nawroth PP; Arnold B
J Clin Invest; 2004 Jun; 113(11):1641-50. PubMed ID: 15173891
[TBL] [Abstract][Full Text] [Related]
11. Unlocking the biology of RAGE in diabetic microvascular complications.
Manigrasso MB; Juranek J; Ramasamy R; Schmidt AM
Trends Endocrinol Metab; 2014 Jan; 25(1):15-22. PubMed ID: 24011512
[TBL] [Abstract][Full Text] [Related]
12. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.
Yan SF; Ramasamy R; Schmidt AM
Expert Rev Mol Med; 2009 Mar; 11():e9. PubMed ID: 19278572
[TBL] [Abstract][Full Text] [Related]
13. RAGE in inflammation: a new therapeutic target?
Bierhaus A; Stern DM; Nawroth PP
Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586
[TBL] [Abstract][Full Text] [Related]
14. [Role of the receptor for advanced glycation end products (RAGE) in inflammation].
Mosquera JA
Invest Clin; 2010 Jun; 51(2):257-68. PubMed ID: 20928981
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
Susa Y; Masuda Y; Imaizumi H; Namiki A
Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
Basta G
Atherosclerosis; 2008 Jan; 196(1):9-21. PubMed ID: 17826783
[TBL] [Abstract][Full Text] [Related]
17. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications.
Bierhaus A; Nawroth PP
Diabetologia; 2009 Nov; 52(11):2251-63. PubMed ID: 19636529
[TBL] [Abstract][Full Text] [Related]
18. DNA-Aptamer Raised against Receptor for Advanced Glycation End Products Improves Survival Rate in Septic Mice.
Koga Y; Sotokawauchi A; Higashimoto Y; Nishino Y; Hashizume N; Kakuma T; Akiba J; Tanaka Y; Matsui T; Yagi M; Yamagishi SI
Oxid Med Cell Longev; 2021; 2021():9932311. PubMed ID: 34413930
[TBL] [Abstract][Full Text] [Related]
19. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.
Tamada K; Nakajima S; Ogawa N; Inada M; Shibasaki H; Sato A; Takasawa R; Yoshimori A; Suzuki Y; Watanabe N; Oyama T; Abe H; Inoue S; Abe T; Yokomizo T; Tanuma S
Biochem Biophys Res Commun; 2019 Apr; 511(3):665-670. PubMed ID: 30826057
[TBL] [Abstract][Full Text] [Related]
20. The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?
Creagh-Brown BC; Quinlan GJ; Evans TW; Burke-Gaffney A
Intensive Care Med; 2010 Oct; 36(10):1644-1656. PubMed ID: 20631986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
